| Aaron Buresh, PHARMD | |
|
3710 57th Ave, Kenosha, WI 53144-4820 | |
| (262) 652-1474 | |
| Not Available |
| Full Name | Aaron Buresh |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 3710 57th Ave, Kenosha, Wisconsin |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053188458 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 22456-40 (Wisconsin) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Aaron Buresh, PHARMD 3710 57th Ave, Kenosha, WI 53144-4820 Ph: () - | Aaron Buresh, PHARMD 3710 57th Ave, Kenosha, WI 53144-4820 Ph: (262) 652-1474 |
News Archive
Milwaukee-based Insurer Assurant Inc. is cutting its workforce in various locations around America ahead of health care reform implementation. The Milwaukee Journal Sentinel reports that 130 jobs in Milwaukee and Plymouth, Minn., will be cut. "The company, which sells health insurance for individuals and small employers as well as short-term policies, faces an onslaught of new federal health care reform regulations, including the requirement that it spend 80% of premiums on medical care.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, today reported its consolidated financial results for the first quarter ended March 31, 2010, and company highlights.
Targeted tumor radiation provides a feasible treatment option for children with difficult-to-treat liver cancer, according to a new study published today in the journal Pediatric Blood and Cancer.
Rep. Andy Harris, the state's only Republican member of Congress, requested the investigation even as lawmakers from both parties - who have used the difficulties of the online insurance marketplace in the run up to this year's gubernatorial election - say they welcome the review.
A cancer-suppressing gene has been successfully delivered into the tumors of stage 4 lung cancer patients via an intravenously administered lipid nanoparticle in a phase I clinical trial at The University of Texas M. D. Anderson Cancer Center.
› Verified 6 days ago
Mitchell Robak, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2207 80th St, Kenosha, WI 53143 Phone: 262-658-3731 | |
Carolyn Schiller, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3820 52nd St, Kenosha, WI 53144 Phone: 262-652-9665 Fax: 262-652-0896 | |
Daniel Lupi, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3805 80th St, Kenosha, WI 53142 Phone: 262-694-0750 | |
Dr. Danielle T Kroll, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 9916 75th St Ste 103, Kenosha, WI 53142 Phone: 262-925-0201 Fax: 262-925-8373 | |
Daisy Nichols, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 7701 Green Bay Rd, Kenosha, WI 53142 Phone: 262-612-1610 | |
Lisa Mutchler, PHARMD. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 7525 Sheridan Rd, Kenosha, WI 53143 Phone: 262-652-2396 |